Here is the latest shareholding Pattern of ASTRAZENECA PHARMA. For more details, see the ASTRAZENECA PHARMA financial fact sheet and ASTRAZENECA PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-21 |
3
Jun-21 |
3
Sep-21 |
3
Dec-21 |
3
Mar-22 |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Foreign Promoters | % | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | |
Total Promoters | % | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | |
Mutual Funds | % | 0.83 | 0.94 | 0.93 | 0.97 | 0.99 | 1.07 | 1.09 | 1.22 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 2.43 | 2.42 | 2.40 | 2.38 | 2.38 | 2.48 | 2.49 | 2.61 | |
Other | % | 0.10 | 0.08 | 0.09 | 0.14 | 0.17 | 0.20 | 0.20 | 0.20 | |
Total Institution | % | 3.36 | 3.44 | 3.45 | 3.52 | 3.57 | 3.78 | 3.81 | 4.03 | |
Bodies Corporate | % | 1.45 | 1.22 | 1.23 | 1.45 | 1.73 | 2.03 | 1.67 | 1.46 | |
Individuals | % | 19.53 | 19.72 | 19.70 | 19.44 | 19.06 | 18.63 | 18.54 | 18.56 | |
NRIs/OCBs | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.41 | 0.39 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 0.66 | 0.62 | 0.62 | 0.59 | 0.64 | 0.56 | 0.56 | 0.56 | |
Total Non-Institution | % | 21.64 | 21.56 | 21.55 | 21.48 | 21.43 | 21.22 | 21.18 | 20.97 | |
Total Public | % | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
![]() |
More Pharmaceuticals Company Shareholding Pattern: PIRAMAL ENTERPRISES ZYDUS LIFESCIENCES AUROBINDO PHARMA LUPIN CIPLA
On Wednesday, Indian share markets witnessed high volatility as Adani group stocks and insurance companies fell sharply in the second half, dampening overall sentiment.